These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 34080454)

  • 1. Retrospective Review of Virologic and Immunologic Response in Treatment-Experienced Patients on Third-Line HIV Therapy in Lusaka, Zambia.
    Zulu PM; Toeque MG; Hachaambwa L; Chirwa L; Fwoloshi S; Siwingwa M; Mbewe M; Rosser JI; Stafford KA; Lindsay B; Mulenga L; Claassen CW
    J Int Assoc Provid AIDS Care; 2021; 20():23259582211022463. PubMed ID: 34080454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-Experienced Patients on Third-Line Therapy: A Retrospective Cohort of Treatment Outcomes at the HIV Advanced Treatment Centre, University Teaching Hospital, Zambia.
    Toeque MG; Lindsay B; Zulu PM; Hachaambwa L; Fwoloshi S; Chanda D; Stafford KA; Mupeta F; Siwingwa M; Mutinta M; Chirwa L; Riedel DJ; Claassen C; Mulenga L
    AIDS Res Hum Retroviruses; 2022 Oct; 38(10):798-805. PubMed ID: 35778849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between gender and HIV viral suppression on third-line therapy in Zambia: a retrospective cohort study.
    Andronescu L; Zulu PM; Jackson SS; Hachaambwa L; Claassen CW; Stafford KA
    Int J STD AIDS; 2019 Apr; 30(5):453-459. PubMed ID: 30999831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa.
    Evans D; Hirasen K; Berhanu R; Malete G; Ive P; Spencer D; Badal-Faesen S; Sanne IM; Fox MP
    AIDS Res Ther; 2018 Apr; 15(1):10. PubMed ID: 29636106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
    Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
    Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia.
    Seu L; Mulenga LB; Siwingwa M; Sikazwe I; Lambwe N; Guffey MB; Chi BH
    J Med Virol; 2015 Jul; 87(7):1149-57. PubMed ID: 25754408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.
    Rewari BB; Bachani D; Rajasekaran S; Deshpande A; Chan PL; Srikantiah P
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):610-4. PubMed ID: 20890211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes.
    Moorhouse M; Maartens G; Venter WDF; Moosa MY; Steegen K; Jamaloodien K; Fox MP; Conradie F
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):73-78. PubMed ID: 30334876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
    Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
    BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.
    Koller M; Fatti G; Chi BH; Keiser O; Hoffmann CJ; Wood R; Prozesky H; Stinson K; Giddy J; Mutevedzi P; Fox MP; Law M; Boulle A; Egger M
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e110-9. PubMed ID: 26470034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy.
    van Dijk JH; Sutcliffe CG; Munsanje B; Sinywimaanzi P; Hamangaba F; Thuma PE; Moss WJ
    PLoS One; 2011 Apr; 6(4):e19006. PubMed ID: 21552521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring.
    Gsponer T; Petersen M; Egger M; Phiri S; Maathuis MH; Boulle A; Musondad P; Tweya H; Peter K; Chi BH; Keiser O;
    AIDS; 2012 Jan; 26(1):57-65. PubMed ID: 22089376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes.
    Rohr JK; Ive P; Horsburgh CR; Berhanu R; Hoffmann CJ; Wood R; Boulle A; Giddy J; Prozesky H; Vinikoor M; Mwanza MW; Wandeler G; Davies MA; Fox MP
    J Acquir Immune Defic Syndr; 2018 Apr; 77(4):413-416. PubMed ID: 29206723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria.
    Meloni ST; Chang CA; Eisen G; Jolayemi T; Banigbe B; Okonkwo PI; Kanki PJ
    PLoS One; 2016; 11(10):e0164030. PubMed ID: 27764094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study.
    Nsanzimana S; Semakula M; Ndahindwa V; Remera E; Sebuhoro D; Uwizihiwe JP; Ford N; Tanner M; Kanters S; Mills EJ; Bucher HC
    BMC Infect Dis; 2019 Apr; 19(1):312. PubMed ID: 30953449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure.
    Boerma RS; Bunupuradah T; Dow D; Fokam J; Kariminia A; Lehman D; Kityo C; Musiime V; Palumbo P; Schoffelen A; Sophan S; Zanoni B; Rinke de Wit TF; Calis JCJ; Sigaloff KCE;
    J Int AIDS Soc; 2017 Sep; 20(1):21930. PubMed ID: 28953325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps.
    Murphy RA; Court R; Maartens G; Sunpath H
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1181-1184. PubMed ID: 28793781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.
    Cuong DD; Sönnerborg A; Van Tam V; El-Khatib Z; Santacatterina M; Marrone G; Chuc NT; Diwan V; Thorson A; Le NK; An PN; Larsson M
    BMC Infect Dis; 2016 Dec; 16(1):759. PubMed ID: 27986077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone.
    Hoffmann CJ; Maritz J; van Zyl GU
    Trop Med Int Health; 2016 Feb; 21(2):219-23. PubMed ID: 26584666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.